Number of credits
|Master in pharmacy (120 ECTS)||3 crédits|
Corinne Charlier, Brigitte Evrard, Marianne Fillet, Pierre Francotte, Michel Frederich, Philippe Hubert, Anna Lechanteur, Allison Ledoux, Geneviève Philippe, Géraldine Piel, Bernard Pirotte, Anne-Catherine Servais, Vincent Seutin, Eric Ziemons
Language(s) of instruction
Organisation and examination
Teaching in the second semester
Units courses prerequisite and corequisite
Prerequisite or corequisite units are presented within each program
Learning unit contents
The integrated work II, dedicated to drugs, succeed to the integrated work I devoted to raw materials (BAC 3 in pharmaceutical sciences).
The students, divided up into small groups of 10-15, will receive 5 pharmaceutical specialities. These pharmaceutical products contain the synthetic or natural active substances, the biomolecules and some excipients on which the students will have already worked during the integrated work I. The drugs will cover different pharmaceutical dosage forms.
The students will have to analyze each drug and write a report which will deal with pharmacology, quality control, pharmaceutical technology, interactions, ....
Learning outcomes of the learning unit
The objective of the integrated work II is to enable the student to integrate the knowledge acquired in the different fields of the studies in pharmaceutical sciences and to get ready for his role of drug expert.
Prerequisite knowledge and skills
· Drug analysis (PHAR0344-3)
· Pharmaceutical analytical chemistry (CHIM0320-3 and CHIM0330-3)
· Medicinal chemistry (CHIM0332-2 and CHIM0333-2)
· Pharmacology (PHAC0130-7, PHAC0341-2 and PHAC0342-2)
· Pharmacognosy (PHAR0331-3 and PHAR0332-2)
· Integrated work I (PHAR2019-1)
· Pharmaceutical technology and biopharmacy (PHAR0330-2 and PHAR0343-3)
· Toxicology (TOXI0341-2 and TOXI0342-2)
Planned learning activities and teaching methods
Mode of delivery (face to face, distance learning, hybrid learning)
The integrated work II will be organized in the 2nd semester:
· one introductive session
· four preparative sessions in small groups
· two questions/answers sessions
· one session for presentation/defense of the reports in small groups.
Attendance during the different preparative sessions of the report is mandatory.
Recommended or required readings
The instructions will be available on eCampus.
The students will post on eCampus the reports for each drug.
Any session :
- If evaluation in "hybrid"
The students will write, by subgroups of 3, a report on the drug they received. Each subgroup will have to present the report (Powerpoint presentation) and defend it in front of a board of examiners belonging to each pharmaceutical field, in the presence of the group. At the beginning of each session, the students will have a writing test in order to evaluate the knowledge about the other drugs of the group. Moreover, during this session, each student will have to be able to answer to the questions concerning the other drugs of his group.
The student will have to write, present and defend his report in front of the examining board again.
Organisational remarks and main changes to the course
Anne-Catherine Servais, PhD